Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Drugs
|
January 1, 1997
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns
A Marchese, E A Debbia, D Bacca, et al.
Journal of Viral Hepatitis
|
October 27, 2004
Treatment of patients with HCV infection with or without liver biopsy
A Andriulli, M Persico, A Iacobellis, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
December 10, 1998
Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Hepatology (Baltimore, Md.)
|
August 8, 1998
Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Journal of Hepatology
|
April 27, 2001
Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial
A Mangi, M R Villani, N Minerva, et al.
Journal of Viral Hepatitis
|
September 3, 2008
Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin
A Andriulli, C Cursaro, R Cozzolongo, et al.
The American Journal of Gastroenterology
|
December 22, 1998
Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Alimentary Pharmacology & Therapeutics
|
March 13, 2010
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin
A Mangia, O Dalgard, N Minerva, et al.
Journal of Hepatology
|
October 11, 2001
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial
G Barbaro, F Zechini, A M Pellicelli, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2001
A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C
A Mangia, N Minerva, M Annese, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Drugs
|
January 1, 1997
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns
A Marchese, E A Debbia, D Bacca, et al.
Journal of Viral Hepatitis
|
October 27, 2004
Treatment of patients with HCV infection with or without liver biopsy
A Andriulli, M Persico, A Iacobellis, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
December 10, 1998
Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Hepatology (Baltimore, Md.)
|
August 8, 1998
Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Journal of Hepatology
|
April 27, 2001
Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial
A Mangi, M R Villani, N Minerva, et al.
Journal of Viral Hepatitis
|
September 3, 2008
Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin
A Andriulli, C Cursaro, R Cozzolongo, et al.
The American Journal of Gastroenterology
|
December 22, 1998
Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study
G Barbaro, G Di Lorenzo, M Soldini, et al.
Alimentary Pharmacology & Therapeutics
|
March 13, 2010
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin
A Mangia, O Dalgard, N Minerva, et al.
Journal of Hepatology
|
October 11, 2001
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial
G Barbaro, F Zechini, A M Pellicelli, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2001
A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C
A Mangia, N Minerva, M Annese, et al.
Page
of 2